0001127602-23-013708.txt : 20230428
0001127602-23-013708.hdr.sgml : 20230428
20230428064620
ACCESSION NUMBER: 0001127602-23-013708
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230427
FILED AS OF DATE: 20230428
DATE AS OF CHANGE: 20230428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Stan
CENTRAL INDEX KEY: 0001913199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 23860041
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-04-27
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913199
Smith Stan
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
0
Common Stock
2023-04-27
4
P
0
133300
2.25
A
686628
I
See Footnote
These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.
These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
/s/ Stan V. Smith
2023-04-28